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Abstract 
 
Background: Heterocyclic amines (HCA) are positively associated with prostate 
cancer risk in animal models. Because of mostly inconsistent results of 
epidemiological studies we examined the association between intake of HCA and 
prostate cancer risk. 
Methods: In the EPIC-Heidelberg cohort, detailed information on diet, anthropometry, 
and lifestyle was assessed between 1994 and 1998. Dietary HCA intake was 
estimated using information on meat consumption, cooking methods, and preferred 
degree of browning. During 104,195 person-years of follow-up, 337 incident cases of 
prostate cancer (123 advanced cases) were identified among 9578 men with valid 
dietary information. Multivariate Cox proportional hazards regression was used to 
examine the association between intake of 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-
amino-3,4,8-dimethylimidazo[4,5-f]quinoxaline (DiMeIQx) and prostate cancer.  
Results: Men in the highest quartiles of PhIP, MeIQx, and DiMeIQx intake, 
respectively, had no increased risk of prostate cancer compared with men in the 
lowest quartiles (HR=0.89, 95% CI 0.66-1.22 [PhIP]; 1.06, 0.77-1.45 [MeIQx]; 0.98, 
0.72-1.34 [DiMeIQx]). There were no associations between HCA intake and 
advanced prostate cancer or between high consumption of strongly browned meat 
and prostate cancer. 
Discussion: Our data do not support the hypothesis that HCA intake as consumed in 
a regular diet is a risk factor for prostate cancer. 
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Introduction 
 
In vitro and in vivo experiments indicate that heterocyclic aromatic amines (HCAs) 
are some of the most potent mutagens [1]. These compounds are formed from amino 
acids, creatin(in)e and sugar during cooking of fish and/or meat at high temperatures. 
The amount depends on cooking temperature, cooking time, type of meat and 
cooking method. The most mass-abundant HCAs detected in cooked meat are 2-
amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo 
[4,5-f]quinoxaline (MeIQx), and 2-amino-3,4,8-dimethylimidazo[4,5-f]quinoxaline 
(DiMeIQx). 
In experimental studies, N-hydroxy derivates of PhIP and of MeIQx were shown to be 
potential carcinogens for the prostate [2]. In a rat model, Nakai et al. [3] have shown 
that an increased proliferation and cell death in response to PhIP, which indicates 
that in addition to PhIP acting as an "initiator" of cancer, PhIP might also act like a 
lobe-specific tumor "promoter". In humans, a number of epidemiological studies have 
shown that high intake of well-done meat and high exposure to meat carcinogens, 
like HCAs, may increase the risk of a number of common cancers such as breast and 
colorectal cancer [4, 5, 6]. For prostate cancer, some studies have evaluated the 
association between consumption of different types of meat and prostate cancer risk. 
Some of them showed a positive association between meat consumption and 
prostate cancer, especially for well-done and red meat [7, 8, 9, 10], but others 
reported no association [11, 12, 13]. The few studies with focus on HCA intake 
revealed inconsistent results; two studies reported no association [8, 10], whereas 
one study indicated an increasing risk for intake of PhIP [9] and another one an 
increased risk for MeIQx and DiMeIQx [7]. 
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Because of mostly inconsistent results, it was the aim of this study to examine the 
association between intake of meat prepared with different degrees of browning and 
HCA
 
 intake with the risk of prostate cancer in the EPIC-Heidelberg cohort study. 
Subjects and Methods 
 
Population 
The EPIC-Heidelberg cohort is part of the European Prospective Investigation into 
Cancer and Nutrition, a prospective cohort study conducted in ten countries. From 
1994 to 1998, a total of 11,928 men aged 40-65 years and 13,612 women aged 35-
65 years were recruited from the general population of Heidelberg and surrounding 
communities. Information on diet, lifestyle and health were obtained at baseline by 
means of questionnaires and face-to-face interviews [14]. The cohort is followed up 
by mailed questionnaires in intervals of about three years to assess information on 
health status, diet and lifestyle [15]. Diet was assessed by using a validated food-
frequency questionnaire (FFQ) [16]. 
During the second follow-up of the cohort (2002-2004), 11,605 men have been 
contacted; of these, 9864 participants completed a 158-item FFQ. This FFQ included 
detailed questions on meat preparation methods and preferred degree of browning, 
i.e. the outside appearance of the meat, using four pictures (lightly/ moderately/ 
strongly/ extremely browned) as reference and assistance. Mean daily dietary intake 
of HCAs from meat was calculated by using published data of the HCA content of 
different types of meat in combination with information on degree of browning, 
cooking methods, and the amount of meat intake [17].  
Identification of incident prostate cancer cases was based on self-reported primary 
prostate cancer during follow-up or on death certificates that were coded for prostate 
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cancer as the underlying cause of death. All cases were verified by medical records, 
death certificates, or both. Information on stage and grade of prostate cancer was 
extracted by the study physician from pathology reports, including tumour nodal 
metastasis (TNM) stage and Gleason histological grade. Advanced prostate cancer 
was defined as prostate cancer with a Gleason sum score equal or higher than 7, a 
TNM staging score of T3/T4, N1-N3, or M1, or prostate cancer as the underlying 
cause of death. Although prone to detection bias, stage T1a cases were included in 
the analysis because their low number (7 T1a cases [2.8% of all cases]) was unlikely 
to affect the results. 
After excluding men with prevalent cancer or with missing information on food 
preparation methods and preferred degree of browning our study population 
comprises a total of 9578 men. Among these, 337 incident cases of prostate cancer 
(including 123 advanced cases, which included 22 fatal cases) have been diagnosed 
until July 31, 2009. 
All participants gave written informed consent. EPIC-Heidelberg has been approved 
by the ethical committee of Heidelberg University Medical School. 
 
Statistical analyses 
The association of total and advanced prostate cancer with intake of the three most 
abundant HCAs (PhIP, MeIQx and DiMeIQx) and meat consumption by degree of 
browning was analyzed using Cox proportional hazards regression, modelling the 
intake variables as a categorical variable based on quartiles of intake in the cohort, 
with the first quartile being the reference category. Age was used as the primary time 
variable in the Cox models. Time at entry was age at recruitment, and time of exit 
was the age at which participants were diagnosed with cancer, died, were lost to 
follow-up, or were censored at the end of the follow-up period, whichever came first. 
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The analyses were stratified by age at recruitment in one-year categories. In 
multivariate regression models, we adjusted for smoking status at baseline (never, 
former, or current), family history of prostate cancer (yes/no), participation in 
prostate-specific antigen (PSA)-screening tests (yes/no) and intake of dairy products 
(entered as quartiles). Additional adjustment for other possible confounders (tomato 
products, body mass index, total energy intake, alcohol intake, and vigorous physical 
activity) had no statistically significant effects on the risk of prostate cancer (p < 
0.20). 
The results are given as hazard ratios (HR) and 95% confidence intervals (CI). We 
also examined whether the observed associations of HCA intake and prostate cancer 
changed if we examined the three HCAs in a combined model additionally controlled 
for red and processed meat (entered as quartiles).  
To test for linear trend across categories we used the continuous variables. All tests 
were two-sided; P values <0.05 were considered to be statistically significant. All 
statistical analyses were performed with SAS software (version 9.1; SAS Institute, 
Cary, NC). 
 
Results 
Baseline characteristics of the study participants are shown in Table 1. Compared 
with men in the lowest quartile of total HCA intake, men in the highest quartile tended 
to have a higher BMI and a higher total energy intake, to consume more alcohol, 
tomato products, a lower consumption of dairy products, and were more likely to be 
current smokers (Table 1). There was no significant association between HCA intake 
and risk of prostate cancer; men in the highest quartiles of PhIP, MeIQx, and 
DiMeIQx intake, respectively, did not have an increased risk of prostate cancer 
compared with men in the lowest quartiles (HR=0.89, 95% CI 0.66-1.22 [PhIP]; 1.06, 
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0.77-1.45 [MeIQx]; 0.98, 0.72-1.34 [DiMeIQx]; Table 2). No statistically significant 
associations were observed when we considered advanced cases (Table 2). In 
addition, we did not see clear relationships with prostate cancer stratified by stage or 
grade (data not shown).  
There were also no consistent associations between consumption of meat by degree 
of browning and total or advanced prostate cancer incidence; men in the second and 
third quartile of strongly and extremely browned meat had an increased risk of 
prostate cancer, but there was not statistically significant association when 
comparing men with the highest consumption of strongly browned meat to those with 
the lowest intake (Table 2). 
As already seen in the entire EPIC cohort [18], we observed no statistically significant 
association between red or processed meat intake and prostate cancer risk in the 
EPIC-Heidelberg cohort (data not shown). 
 
Discussion 
In this prospective cohort study, the estimated dietary intake of HCAs was not 
associated with the risk of prostate cancer. The consumption of strongly/extremely 
browned meat was also not consistently related to prostate cancer incidence. 
 
Our result of no association between HCA intake and prostate cancer incidence is 
comparable with some [8, 10] but not other [7, 9] previous studies. A case-control 
study with 317 cases in New Zealand [8] did not find an association between HCA 
intake and prostate cancer risk. Cross et al. [9] observed in their cohort study with 
29,361 men and 868 incident cases of prostate cancer no association between intake 
of different types of meat or the intake of MeIQx and DiMeIQx, respectively, and risk 
of prostate cancer. However, an increased risk of prostate cancer was observed in 
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subjects with high intake of PhIP [all cases: relative risk (RR) 1.22, 95% CI (1.01-
1.48); incident cases: 1.28, 95% CI (1.01-1.61), top vs bottom quintile] and very well-
done meat [all cases: RR 1.42, 95% CI (1.05-1.92); incident cases: 1.69, 95% CI 
(1.19-2.40)]. Within the Agricultural Health Study, Koutros et al. [6] observed a 
positive association of well and very well-done meat consumption with risk of 
prostate cancer. For MeIQx and DiMeIQx intake, they observed a non-significantly 
increased risk of prostate cancer. In a large prospective cohort study in the US, a 
high intake of red, processed as well as grilled/barbecued meat were associated with 
elevated risks of total and advanced prostate cancer, but they did not observe 
statistically significant associations between HCA intake and prostate cancer [10]. 
 
The estimation of daily HCA intake is mostly based on data derived from FFQs that 
are commonly used in epidemiological studies. However, HCA intake estimations 
suffer from imprecision. Assessing a person’s dietary intake by means of a FFQ is 
prone to recall bias, such that study participants may over- or underestimate their 
dietary intake leading to misclassification with respect to dietary intake. Second, the 
use of limited data on the HCA content in differently prepared meats for the 
computation of HCA intake [17] is another major shortcoming of this approach to 
quantify intake. HCA intake was lower in our cohort than in previous studies, in 
particular US studies, and food sources contributing most to HCA intake also differs 
between studies [17]. This may partly explain differences in results between studies. 
However, we have previously shown in our cohort a positive association between 
HCA intake, in particular PhIP, and the risk of colorectal adenomas [5], which is in 
line with findings from other studies. HCA formation is a function of duration and 
temperature of the cooking process as well as of the cooking method itself [19], such 
that the content of HCAs depends on the degree of browning as well as on the 
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degree of doneness of the meat. For example, cooking short time by high 
temperature and long time by lower temperature can result in the same degree of 
browning but not in the same degree of doneness and, thus, in different amounts of 
HCAs. It has been shown that this effect may lead to an underestimation of exposure 
[19]. Nevertheless, recent investigations have shown that validated FFQs can result 
in reasonable estimations of levels of HCA intake [20]. Kobayashi et al. [21] 
compared the intake of some HCAs and total HCA intake estimated from a FFQ with 
the PhIP level in hair samples. Under adjustment for melanin content, they observed 
statistically significant correlations for PhIP and total HCA intake by FFQ with the 
respective levels in hair (r = 0.47 and r = 0.51, respectively) [22].  
The results of our and also some other studies showing no association between 
intake of HCA and prostate cancer risk could possibly be explained by the fact that 
food, e.g. processed meat, also contains other compounds than HCAs that can act 
as mutagens/carcinogens. Nitrite and nitrate, polycyclic aromatic hydrocarbons and 
heme iron are such compounds [10, 23]. In this case, however, one might expect a 
positive association between meat, meat subgroups (e.g. red or processed meat), or 
strongly browned meat as reported by Sinha et al. [10]. However, we did not observe 
a consistently increased risk of prostate cancer with high consumption of 
strongly/extremely browned meat. A second factor that needs to be taken into 
account is the role of genetic polymorphisms that affect the metabolism of HCAs and, 
thus, their potential carcinogenic effect [24]. Thirdly, it is difficult to consider all factors 
that can affect and modulate the risk of prostate cancer; bias arising from 
unrecognized confounding remains a potential weak point in any observational study 
design especially because there are only few well-recognized prostate cancer risk 
factors. Lastly, the number of cases in our study is smaller than in other studies [9, 
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10, 24] and the power was, thus, lower to observe a small to moderate but 
statistically significant association. 
In conclusion, our data do not support the hypothesis that HCA intake as consumed 
in a regular diet is a risk factor for prostate cancer. 
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<26.09 26.09 to < 61.45 61.45 to <148.14 ≥ 148.14 P value1
Total (n) 2394 2395 2394 2395 0.02
Cases (n, %) 99 (4.1) 97 (4.1) 70 (2.9) 71 (3.0) 0.01
Advanced (n, %) 36 (1.5) 37 (1.5) 31 (1.3) 19 (0.8) 0.02
Age (years)2 52.9±7.1 52.5±7.1 51.4±6.9 50.8±7.0 <0.01
Body mass index (kg/m²)2 26.3±3.4 26.7±3.4 27.1±3.7 27.4±3.7 <0.01
HCA intake (ng/d)
PhIP3 6.7 (0.0-24.1) 22.6 (0.5-59.5) 59.9 (1.0-143.9) 197.2 (32.1-5967) <0.01
MeIQx3 4.8 (0.0-23.0) 14.6 (0.0-44.9) 28.5 (0.4-101.5) 69.5 (1.7-3097) <0.01
DiMeIQx3 0.7 (0.0-9.1) 1.9 (0.0-14.6) 3.3 (0.0-26.3) 5.1 (0.0-271.0) <0.01
Energy intake (kcal/d)2 1999±632 2130±623 2291±830 2407±853 <0.01
Dairy products (g/d)2 253.0±270.0 228.0±224.0 233.7±231.7 232.9±245.8 <0.01
Tomatoes, tomato products (g/d)2 (g/d)* 22.4±15.2 22.8±13.8 24.4±15.5 25.9±21.5 <0.01
Red meat (g/d)2 22.6±20.1 36.1±23.2 47.4±31.2 58.7±48.0 <0.01
Processed meat (g/d)2 45.1±35 61.2±39.5 72.6±49.5 78.4±57.6 <0.01
White meat (g/d)2 8.5±9.7 13.5±13.7 14.9±14.3 18.8±20.3 <0.01
Alcohol (g/d)2 22.0±26.3 25.9±26.0 26.4±26.6 28.0±28.0 <0.01
Vigorous physical activity (%)4
None 34.3 34.3 34 31.5 0.08
≤ 2 h/wk 38.9 37.5 37.2 37.8 0.61
> 2h/wk 26.9 28.1 28.8 30.7 <0.01
Smoking status (%)
Never 36.1 32 28.7 29 <0.01
Former 48 47.5 46.8 45.6 0.09
Current 15.9 20.5 24.6 25.3 <0.01
Family history of prostate cancer (%) 4.7 4.1 4.1 3.9 0.2
Participation in PSA screening (%)5 63.2 62.3 57.4 58.5 0.02
1 Jonckheere-Terpstra Test.
2 Mean ± SD 
3  Median and interquartile range by quintile of total HCA intake
4 Unknown/ missing information on physical activity for 101/ 91 participants.
5 758 participants with no information about PSA screening
Quartiles of total HCA intake [ng/day]
Table 1. Baseline characteristics of men of the EPIC-Heidelberg cohort over quartiles of total HCA 
intake
1
HR HR 95% CI HR HR 95% CI
PhIP [ng/day] <13.06
All cases (n) 100
HR2 1.00 (ref.) 1.04 (0.78,1.37) 0.80 0.90 (0.66,1.22)
HR3 1.00 (ref.) 1.02 (0.77,1.35) 0.83 0.89 (0.66,1.22)
HR4 1.00 (ref.) 0.93 (0.69,1.27) 0.74 0.76 (0.49,1.17)
Advanced cases (n) 30
HR3 1.00 (ref.) 1.56 (0.98,2.48) 1.07 0.89 (0.51,1.56)
MeIQx [ng/day] <8.03
All cases (n) 88
HR2 1.00 (ref.) 1.18 (0.88,1.57) 1.03 1.03 (0.76,1.42)
HR3 1.00 (ref.) 1.14 (0.85,1.52) 1.07 1.06 (0.77,1.45)
HR4 1.00 (ref.) 1.24 (0.89,1.72) 1.29 1.45 (0.88,2.41)
Advanced cases (n) 32
HR3 1.00 (ref.) 1.20 (0.74,1.92) 1.12 0.91 (0.53,1.57)
DiMeIQx [ng/day] <0.74
All cases (n) 89
HR² 1.00 (ref.) 0.99 (0.73,1.33) 1.04 1.00 (0.73,1.36)
HR3 1.00 (ref.) 0.94 (0.69,1.26) 1.01 0.98 (0.72,1.34)
HR4 1.00 (ref.) 0.90 (0.66,1.22) 0.95 0.99 (0.67,1.45)
Advanced cases (n) 27
HR3 1.00 (ref.) 1.24 (0.75,2.06) 1.37 1.05 (0.61,1.82)
Degree of browning
Strong/extreme [g/day] <2.38
All cases (n) 55
HR3 1.00 (ref.) 1.48 (1.04,2.11) 1.45 1.05 (0.69, 1.60)
Advanced (n) 24
HR3 1.00 (ref.) 1.70 (1.02,2.83) 1.66 0.94 (0.50,1.77)
Light/moderate [g/day] <8.67
All cases (n) 53
HR3 1.00 (ref.) 0.93 (0.64,1.35) 1.06 0.75 (0.51,1.11)
Advanced cases (n) 26
HR3 1.00 (ref.) 1.10 (0.65,1.84) 1.00 0.73 (0.41,1.28)
1 Trend tests were performed using the continuous intake of each variable.
2 Cox proportional hazards models, stratified by age.
Table 2. Hazard ratios (HR) and 95% CI of prostate cancer across quartiles of PhIP, MeIQx and DiMeIQx intake 
and consumption of meat with different degree of browning
33 32 23
0.26
(0.59,1.68) 0.21
58 70 51
(0.74,1.52)
(0.98,2.80) 0.16
8.67 - <21.67 21.67 - <40.91 ≥40.91
(1.01,2.09) 0.87
39 34 17
73 65 39
2.38 - <14.44 14.44 - <35.13 ≥35.13
34 37 25
(0.83,2.26) 0.71
0.91
(0.75,1.35) 0.84
(0.68,1.33) 0.88
0.74 - <2.06 2.06 - <4.71 ≥4.71
(0.78,1.40)
0.91
85 89 74
38 30 23
(0.68,1.86)
(0.78,1.45) 0.67
(0.87,1.92) 0.37
18.94 - <41.65 ≥41.65
(0.76,1.39) 0.72
99 78 72
8.03 - <18.94
45 27 21
(0.63,1.81) 0.49
0.86
(0.61,1.13) 0.86
(0.51,1.06) 0.58
13.06 - <36.11 36.11 - <98.45 ≥98.45
(0.59,1.08)
98 69 70
3 Cox proportional hazards models, stratified by age and adjusted for smoking (never, former, current), family history of 
prostate cancer, participation in PSA screening and intake of dairy products (entered as quartile-dummies).
4 Combined Cox proportional hazards models for the three HCAs, stratified and adjusted as in footnote 2, with 
additional adjustment for intake of processed and red meat (quartiles).
Quartile
P  for trend12 3 4
95% CI
